Researchers from GW, FDA, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute.
Rohan Fernandes, PhD, received more than $1.6 million from the National Institutes of Health to investigate nanoimmunotherapies for cancer
The GW Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established...
For the first time, researchers at the GW School of Medicine and Health Sciences have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which...
Researchers at the GW School of Medicine and Health Sciences will look for unknown genes associated with branchiootorenal spectrum disorders.
Researchers from the GW School of Medicine and Health Sciences received more than $3.1 million from the National Institutes of Health to investigate the causes of cardiovascular disease in HIV-infected patients
A team from GW led by Adam Friedman, MD, reviewed 35 studies on treatments for prurigo nodularis.
Researchers at SMHS found dermatologists are interested in learning more about and recommending therapeutic cannabinoids to patients.
Tatiana Znayenko-Miller, a graduate student in the Integrative Medicine Program, was awarded a grant from the BUCK Cancer Foundation.
The GW School of Medicine and Health Sciences and La Clinica del Pueblo have partnered to launch Project ECHO in Washington, D.C. to increase workforce capacity to provide best practice specialty care and reduce health disparities.